NCT06469424 An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU) Status RECRUITING Phase N/A
NCT06459297 Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis or Crohn's Disease Status COMPLETED Phase N/A
NCT06453317 Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06449820 Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis Status COMPLETED Phase N/A
NCT06439641 Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT06424769 Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management Status ENROLLING_BY_INVITATION Phase NA
NCT06421818 Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06407674 Non-invasive Assessment of RECTUM (POUCH) by US (RECT-US) in a Cohort of IBD Patients Status RECRUITING Phase N/A
NCT06405087 A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) Status RECRUITING Phase PHASE3
NCT06398808 A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates Status COMPLETED Phase PHASE2
NCT06392061 Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease Status RECRUITING Phase NA
NCT06381518 Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT06363383 A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants Status COMPLETED Phase PHASE1
NCT06353828 Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06351696 The Effects of Bromelain Supplement in Patients With Ulcerative Colitis Status RECRUITING Phase NA
NCT06335160 Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine Status RECRUITING Phase NA